From: COVID-19 among patients with orthopedic surgery: our experience from the Middle East
Variables | Statistics |
---|---|
Age, yrs | 34.0 ± 6.8 |
Sex, no. (%) | Â |
 Male | `13 (50) |
 Female | 13 (50) |
Underlying disease, no. (%) | Â |
 None | 25 (96.2) |
 Diabetes | 1 (3.8) |
 Asthma | 0 |
 Cardiac | 0 |
Symptoms, no. (%) | Â |
 Fever | 11 (42.3) |
 Headache | 5 (19.2) |
 Cough | 10 (38.5) |
 Myalgia | 6 (23.1) |
 Dyspnea | 4 (15.4) |
 Anosmia | 3 (11.5) |
 Respiratory distress | 1 (3.8) |
 Gastrointestinal symptoms | 2 (7.7) |
 Hypertension, cardiac disease, and lung disease | 0 |
 Hypertension and diabetes | 0 |
Smoker, no. (%) | Â |
 Yes | 3 (11.5) |
 No | 23 (88.5) |
Drug abuse, no. (%) | Â |
 Yes | 0 |
 No | 26 (100) |
Duration of treatment, days | 5.65 ± 1.72 |